CLINICAL_TRIALS
trial_result
· 2024-06-13
Clinical Trial Update: Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis [Phase 2]
Summary
A Phase 2 trial evaluating tradipitant for treatment-resistant pruritus in atopic dermatitis has completed, with the results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2024-06-13